Medical Facilities Corporation
TSX:DR.TOMedical - Care Facilities
+$0.18 today
- Market cap
- $282.43M
- Beta
- 0.34
- P/E (TTM)
- 8.7
- EPS (TTM)
- $1.47
- Dividend yield
- 2.00%
Volume 0.02M
Average 0.02M
DR.TO Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Medical Facilities CorporationTSX: DR.TO
{ "id": "headlineRatioNarrows", "params": { "amount": { "type": "amount", "value": 0.38144835911264313 } } }
[ { "id": "ratioLevelDown", "params": { "amount": { "type": "amount", "value": 0.38144835911264313 }, "period": { "type": "period", "period": { "kind": "quarter", "fiscalYear": 2026, "fiscalQuarter": 1 } }, "change": { "type": "change", "value": 28.2330185567583 } } }, { "id": "ratioTtmDown", "params": { "amount": { "type": "amount", "value": 0.4454137122446358 }, "change": { "type": "change", "value": 21.262192885246733 } } }, { "id": "longRunNarrowed", "params": { "years": { "type": "count", "value": 3 }, "change": { "type": "change", "value": 28.129019298470247 } } } ]
Context
- { "id": "streakWidened", "params": { "rises": { "type": "count", "value": 1 }, "years": { "type": "count", "value": 3 } }, "count": 3 }
- { "id": "extremeLowestLevel", "params": { "fiscalYear": { "type": "fiscalYear", "value": 2025 }, "years": { "type": "count", "value": 4 } } }
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 38.0%
- Year-over-year change
- -28.4pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 38.0% | -28.4pp |
| FY2024 | 2024-12-31 | 66.3% | -0.3pp |
| FY2023 | 2023-12-31 | 66.6% | +0.5pp |
| FY2022 | 2022-12-31 | 66.1% | -1.3pp |
| FY2021 | 2021-12-31 | 67.4% | — |
Gross Margin vs competitors
How DR.TO compares with its peers on the latest reported figures
- { "id": "valueRankMedian", "params": { "ticker": { "type": "text", "value": "DR.TO" }, "period": { "type": "peerPeriod", "period": { "kind": "ltm", "date": "2026-03-31" } }, "amount": { "type": "amount", "value": 0.4454137122446358 }, "rank": { "type": "rank", "position": 5, "total": 8, "direction": "high", "bySize": false }, "count": { "type": "count", "value": 8 }, "median": { "type": "amount", "value": 0.4754802416659309 } } }
- { "id": "yoyRankMedian", "params": { "change": { "type": "signedChange", "value": -21.262192885246733 }, "rank": { "type": "rank", "position": 7, "total": 8, "direction": "high", "bySize": false }, "count": { "type": "count", "value": 8 }, "median": { "type": "signedChange", "value": -3.0537094769966746 } } }
- { "id": "threeYearChange", "params": { "change": { "type": "signedChange", "value": -28.129019298470247 }, "median": { "type": "signedChange", "value": 12.998803238922545 } } }
| Company | Period | YoY | 3-year change | |
|---|---|---|---|---|
| — | 92.2% | +1.9 pp | -2.8 pp | |
PRN.TOProfound Medical Corp. | — | 71.0% | +4.1 pp | +25.6 pp |
| — | 50.9% | -0.7 pp | +0.4 pp | |
| — | 47.5% | -5.8 pp | +39.8 pp | |
| — | 44.5% | -21.3 pp | -28.1 pp | |
| — | 26.5% | -3.1 pp | -3.8 pp | |
| — | 23.6% | -5.9 pp | +54.0 pp | |
| — | -3.1% | -35.8 pp | — | |
| — | — | — | — | |
| Peer median (excluding DR.TO) | 47.5% | -3.1 pp | +13.0 pp | |
Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 398.63M | 424.55M | 445.58M | 331.53M | 258.62M |
| Cost of Revenue | 130.03M | 143.93M | 148.9M | 111.65M | 160.42M |
| Gross Profit | 268.61M | 280.63M | 296.68M | 219.88M | 98.2M |
| Gross Margin | 67.4% | 66.1% | 66.6% | 66.3% | 38.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 177.58M | 198.21M | 151.73M | 151.12M | 119.23M |
| Operating Expenses | 191.25M | 245.69M | 229.57M | 158.24M | 50.72M |
| Depreciation & Amortization | 26.77M | 20.76M | 21.54M | 19.37M | 11.94M |
| EBITDA | 103.4M | 51.15M | 72.43M | 82.57M | 59.41M |
| EBITDA Margin | 25.9% | 12.0% | 16.3% | 24.9% | 23.0% |
| Operating Income | 77.36M | 34.94M | 67.11M | 61.64M | 47.47M |
| Operating Margin | 19.4% | 8.2% | 15.1% | 18.6% | 18.4% |
| Interest Income | 76K | 8.54M | 717K | 1.87M | 2.24M |
| Interest Expense | 25.74M | 12.89M | 16.5M | 12.09M | 3.59M |
| Other Income / Expenses | (26.47M) | (17.44M) | (14.27M) | (10.53M) | (7.19M) |
| Income Before Tax | 50.89M | 17.5M | 52.32M | 51.11M | 40.28M |
| Pre-Tax Margin | 12.8% | 4.1% | 11.7% | 15.4% | 15.6% |
| Income Tax Expense | 4.4M | 5.21M | 8.33M | (5.69M) | 5.06M |
| Net Income | 15.5M | (4.41M) | 18.5M | 73.49M | 21.08M |
| Net Margin | 3.9% | -1.0% | 4.2% | 22.2% | 8.2% |
| EPS (Basic) | 1.50 | 0.42 | 0.73 | 1.03 | 1.09 |
| EPS (Diluted) | 1.49 | 0.42 | 0.73 | 1.03 | 1.09 |
| Weighted Avg Shares | 31.09M | 29.37M | 25.35M | 18.5M | 19.48M |
| Weighted Avg Shares (Diluted) | 31.13M | 29.37M | 25.25M | 24M | 19.48M |
Medical Facilities Corporation
TSX:DR.TO
Intrinsic Alpha fair value
Locked
Current Price
$17.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.